Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
23.08.24
/
50%
€0.18
Target price
23.08.25
€26.85
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 23.08.25. The prediction end date can be changed by Chardan_Capital at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sonnet Biotherapeutics Holdings Inc. | - | - |
iShares Core DAX® | 1.164% | 1.549% |
iShares Nasdaq 100 | 0.118% | 0.969% |
iShares Nikkei 225® | 1.124% | -1.120% |
iShares S&P 500 | 0.479% | 1.068% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $30.00 price target on the stock.
Ratings data for SONN provided by MarketBeat
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.05.24
28.05.24
€27.57
28.05.25
28.05.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.38
16.08.23
16.08.23
€11.00
16.08.24
16.08.24
-51.06%
17.08.24
17.08.24